RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 81 filers reported holding RECRO PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $11,120,000 | -36.8% | 1,010,000 | -46.9% | 0.38% | -44.4% |
| Q4 2017 | $17,591,000 | +3.0% | 1,901,685 | 0.0% | 0.69% | -10.0% |
| Q3 2017 | $17,077,000 | +27.7% | 1,901,685 | 0.0% | 0.77% | +7.9% |
| Q2 2017 | $13,369,000 | -26.3% | 1,901,685 | -8.4% | 0.71% | +2.0% |
| Q1 2017 | $18,136,000 | +8.4% | 2,075,000 | 0.0% | 0.70% | +1.6% |
| Q4 2016 | $16,725,000 | – | 2,075,000 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |